Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how by Aspazia Spyrou, André-Guy Martin, Jean-Michel Hannoun-Lévi, Alexandra Stewart

Get full text

Differential outcomes of re-stratified high-risk prostate cancer patients treated with external beam radiation therapy plus high-dose-rate brachytherapy boost by Damien Carignan, Brandon Morales, Philippe Després, William Foster, André-Guy Martin, Eric Vigneault

Get full text

Advantages of TRUS-based delineation for high-dose-rate prostate brachytherapy planning by Heloise Lavoie-Gagnon, Andre-Guy Martin, Eric Poulin, Louis Archambault, Laurie Pilote, William Foster, Eric Vigneault, Damien Carignan, Frederic Lacroix

Get full text

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer by Lara Hathout, MD, FRCPC, Omar Mahmoud, MD, PhD, Yaqun Wang, PhD, Irina Vergalasova, PhD, Maroie Barkati, MD, FRCPC, Philippe Després, PhD, André-Guy Martin, MD, MSc, FRCPC, William Foster, MD, FRCPC, Frédéric Lacroix, PhD, Guila Delouya, MD, MSc, FRCPC, Daniel Taussky, MD, FRCPC, Gerard Morton, MD, FRCPC, Eric Vigneault, MD, MSc, FRCPC

Get full text